Ethical Considerations at the Intersection Between Psychedelic-Assisted Psychotherapy and Medical Assistance in Dying
AJOB Neuroscience April 3, 2023 Daniel Rosenbaum, Matthew Cho, Evan Schneider et al. 11 citations
No Summary
Matthew Cho
3 papers in the library · 13 citations · publishing 2023-2025
Papers
The Use of Psychedelics for Grief Following Death due to Advanced Illness: A Scoping Review.
Omega July 10, 2025 Daniel Rosenbaum, Celina Carter, Brandon A Cirella et al. 1 citation
A scoping review of 18 reports found little high-quality evidence on using psychedelic-assisted psychotherapy for grief following death due to advanced illness. Across seven empirical studies, positive outcomes such as reduced grief symptom severity were generally reported, with few adverse events. The literature is informed by differing conceptualizations of grief, adding complexity. The review concludes there is not a strong evidence base to guide clinical recommendations at this time and suggests future work should explicitly situate researchers' positions and integrate grief theory.
Psychedelics in medicine - a call for educational action.
Can Med Educ J August 30, 2024 Daniel Shane, Matthew Cho, Sabrina Akhtar 1 citation
The article argues that medical education must adapt to prepare physicians for the growing clinical use of psychedelics. It calls for curriculum development to address knowledge gaps about psychedelic-assisted therapies, including their mechanisms, indications, and safety protocols. The authors assert that without educational action, healthcare systems risk inadequate patient care and missed opportunities for innovation. The piece reviews current research trends and regulatory changes, emphasizing the need for interdisciplinary training that integrates pharmacology, ethics, and psychotherapy. It concludes that proactive educational reform is essential to ensure competent and ethical integration of psychedelics into medicine.